top of page

EPIDIOLEX

Project Date: 2018 - 2019

The first and only FDA-approved prescription cannabidiol (CBD) to treat seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients 1 year of age or older.

Client

Greenwich Biosciences

NY Creative Lead

Type of Work

Campaign Refresh

Branding

PH Creative Lead

Revitalize and elevate the EPIDIOLEX narrative with captivating visuals, transforming and unifying all campaign materials to create a seamless and compelling brand experience.

Task: Conceptualize, design and strategize

bottom of page